Pharmacyte Biotech Inc (PMCB) stock is lower by -28.82% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives PMCB stock a score of 14 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 14. PMCB's rank also includes a short-term technical score of 27. PMCB has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on PMCB!